COVID-19 (SARS-CoV-2 infection) Infections and Infestations
Conditions
Interventions
The AERATOR study will be carried out using specialist equipment in operating theatres and wards to measure real-life aerosol generation in five clinical settings: dental, orthopaedic, respiratory, cr
Sponsors
North Bristol NHS Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients: 1. Undergoing procedure that is potentially aerosol-generating 2. Aged over 18 3. Have capacity Healthy volunteers: 1. Have capacity to consent to the study 2. Aged over 18
Exclusion criteria
Exclusion criteria: Patients: 1. Unable to read/understand PIS (either printed version or via translator) 2. Unable to consent Healthy volunteers: 1. Flu-like symptoms (fevers, temperature, new cough, sore throat, loss of smell, breathing difficulties) in the 48 hours prior to study enrolment 2. Clinical contraindication to the procedure being performed
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Distribution of aerosol produced during routine or simulated procedures measured using Aerodynamic Particle Sensors during the procedure, and for up to 10 minutes after 2. Distribution of aerosol produced during routine or simulated procedures measured using Optical Particle Sensors during the procedure, and for up to 10 minutes after | — |
Secondary
| Measure | Time frame |
|---|---|
| Distribution of aerosol produced and dissemination measured with Aerodynamic and Optical Particle sensors across a clinical room during procedures and for up to 1 hour after | — |
Countries
England, United Kingdom
Contacts
Public ContactFergus Hamilton
Outcome results
None listed